Not Signed In - Genta Provides Update On Analysis Of Phase 3 Trial Of Genasense(R) In Older Patients With Acute Myelogenous Leukemia
Sat, 09 Dec 2006 08:00 AM EST
... Genta Incorporated (Nasdaq: GNTA) today announced that the Company has been notified of preliminary results from a randomized Phase 3 trial of chemotherapy with or without Genasense(R) (oblimersen sodium) Injection that was conducted in older, previously untreated patients with acute myelogenous leukemia. [click link for full article] ...
Related Topics
- Leukemia
- Clinical Trials
- Older Adults
- Myelogenous Leukemia, Chronic
- Leukemia, Chronic Myelogenous
- Chronic Myelogenous Leukemia
- Acute myelogenous leukemia
- Acute myelogenous leukemia cancer
- Data Analysis
- Leukemia, Childhood
- Childhood Leukemia
- Leukemia, Adult Acute
- Adult Acute Myeloid Leukemia
- Chronic myelogenous leukemia cancer
- Adult Acute Lymphoblastic Leukemia
- Childhood Acute Myeloid Leukemia
- Childhood Acute Lymphoblastic Leukemia
- Leukemia, Acute Myeloid, Adult
- Leukemia, Acute Myeloid, Childhood
- Acute Lymphoblastic Leukemia, Childhood
email this page
print this page
bookmark this page
feedback on this page
